Karen Haas to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Karen Haas has written about Xenograft Model Antitumor Assays.
Connection Strength
0.213
-
Dyevoich AM, Haas KM. Type I IFN, Ly6C+ cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination. Mol Cancer Ther. 2020 06; 19(6):1232-1242.
Score: 0.158
-
Smith MR, Dixon CB, Wang Y, Liu Y, D'Agostino R, Ruiz J, Oliver G, Miller LD, Topaloglu U, Chan MD, Farris M, Su J, Mileham KF, Zhao D, Li W, Sexton T, Lycan T, Haas KM, Grayson JM, Xing F. Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung Cancer. Cancer Res. 2024 Dec 02; 84(23):4002-4016.
Score: 0.055